Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Exchange Rate Effect (2016 - 2025)

Avanos Medical (AVNS) has disclosed Exchange Rate Effect for 13 consecutive years, with $600000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 114.29% to $600000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, up 221.95% year-over-year, with the annual reading at $5.0 million for FY2025, 221.95% up from the prior year.
  • Exchange Rate Effect hit $600000.0 in Q4 2025 for Avanos Medical, up from -$300000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $3.8 million in Q4 2022 to a low of -$4.2 million in Q4 2024.
  • Historically, Exchange Rate Effect has averaged -$310526.3 across 5 years, with a median of -$500000.0 in 2024.
  • Biggest five-year swings in Exchange Rate Effect: crashed 1050.0% in 2022 and later surged 680.0% in 2025.
  • Year by year, Exchange Rate Effect stood at -$900000.0 in 2021, then surged by 522.22% to $3.8 million in 2022, then tumbled by 57.89% to $1.6 million in 2023, then plummeted by 362.5% to -$4.2 million in 2024, then surged by 114.29% to $600000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for AVNS at $600000.0 in Q4 2025, -$300000.0 in Q3 2025, and $2.9 million in Q2 2025.